基于CiteSpace的带状疱疹疫苗的研究进展及可视化分析
|
摘要
目的利用可视化分析软件,对带状疱疹疫苗的研究现状、研究热点、发展趋势等进行客观全面地展示与分析,为带状疱疹的研究提供指导与参考。方法以Web of Science数据库为检索对象,纳入1980—2017年发表的与带状疱疹疫苗研究相关的文献,应用CiteSpace 5.2.R2版软件对作者、机构、国家、关键词、被引文献等进行可视化分析。结果最终纳入2155篇符合要求的文章,发文量逐年增加,国际上对于带状疱疹疫苗的研究不断热化,美国的发文量最多,美国疾病预防控制中心、美国科罗拉多大学、美国斯坦福大学、美国哥伦比亚大学等机构所发表的文章居前,日本、欧洲也在该领域有比较深入的研究,各个作者、机构之间的合作较为紧密。结论带状疱疹疫苗的研究仍处于新兴阶段,具有很强的发展潜力;美国、欧洲、日本对带状疱疹的研究处于世界领先水平;中国在带状疱疹疫苗领域的研究与国际同行相比存在很大的差距。
Objective To conduct an objective and comprehensive analysis of the international research status,research hotspots and development trends of herpes zoster vaccine based on visual analysis software,and provide useful guidance and reference for the research of herpes zoster. Methods The Web of Science database was used as the search object,and the articles related to the herpes zoster vaccine published from 1980 to 2017 were included. Visualizing analysis of the authors,institutions,countries,key words and cited documents was conducted based on Cite Space 5.2. R2. Results A total of 2155 articles were eventually included,and the number of a publication increased year by year. The international research on the herpes zoster vaccine continues to heat up. The USA has the largest number of publications. The leading institutions were Center for Disease Control and Prevention( USA),the University of Colorado,Stanford University,and Columbia University. Japan and Europe also have conducted in-depth research in this field. The leading authors and agencies have a relatively close relationship.Conclusion The study of herpes zoster vaccine is still under development,which has strong potential. The researches on herpes zoster in USA,Europe,and Japan ranks among the top in the world; China still lags behind its international peers.
Objective To conduct an objective and comprehensive analysis of the international research status,research hotspots and development trends of herpes zoster vaccine based on visual analysis software,and provide useful guidance and reference for the research of herpes zoster. Methods The Web of Science database was used as the search object,and the articles related to the herpes zoster vaccine published from 1980 to 2017 were included. Visualizing analysis of the authors,institutions,countries,key words and cited documents was conducted based on Cite Space 5.2. R2. Results A total of 2155 articles were eventually included,and the number of a publication increased year by year. The international research on the herpes zoster vaccine continues to heat up. The USA has the largest number of publications. The leading institutions were Center for Disease Control and Prevention( USA),the University of Colorado,Stanford University,and Columbia University. Japan and Europe also have conducted in-depth research in this field. The leading authors and agencies have a relatively close relationship.Conclusion The study of herpes zoster vaccine is still under development,which has strong potential. The researches on herpes zoster in USA,Europe,and Japan ranks among the top in the world; China still lags behind its international peers.
引文
[1]GILDEN D,MAHALINGAM R,NAGEL M A,et al.Review:the neurobiology of varicella zoster virus infection[J].Neuropath App Neurobiol,2011,37(5):441-463.
[2]GERSHON A A,HUTTO C.Varicella-zoster virus[J].Aus Inf Cont,1996,9(3):361.
[3]GERSHON A A,STEINBERG S,BRUNELL P A.Zoster immune globulin,a further assessment[J].New Engl JMed,1974,290(5):243.
[4]INSINGA R P,ITZLER R F,PELLISSIER J M,et al.The incidence of herpes zoster in a United States administrative database[J].J Gene Int Med,2005,20(8):748-753.
[5]张锡宝,曾凡钦.水痘及带状疱疹治疗现状和进展[J].皮肤性病诊疗学杂志,2001,8(1):54-57.
[6]吴根鹏,朱为.水痘-带状疱疹疫苗的使用现状及研究进展[J].中国生物制品学杂志,2016,29(3):323-328.
[7]KATZ S L.Varicella and herpes zoster vaccines:WHOposition paper,June 2014[J].Wkly Epidemiol Rec,2014,89(25):265-287.
[8]SCHMIDT-CHANASIT J,SAUERBREI A.Evolution and world-wide distribution of varicella-zoster virus clades[J].Inf Gene Evol J Mole Epidem Evoly Gene Inf Dis,2011,11(1):1-10.
[9]李杰,陈超美.CiteSpace:科技文本挖掘及可视化[M].北京:首都经济贸易大学出版社,2006:1-244.
[10]SYNNESTVEDT M B,CHEN C,HOLMES J H.Cite Space II:visualization and knowledge discovery in bibliographic databases[J].AMIA Annu Symp Proc,2005:724-728.
[11]CHEN C.CiteSpace II:detecting and visualizing emerging trends and transient patterns in scientific literature[J].JAsso Inf Sci Technol,2009,57(3):359-377.
[12]SANFORD M,KEATING G M.Zoster vaccine(Zostavax):a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults[J].Drugs Aging,2010,27(2):159-176.
[13]MERCK&CO.,INC.Zoster vaccine(Zostavax)[DB/OL].[2009-02-05].http://www.merck.com/product/patent/home.html.
[14]ARVIN A M,POLLARD R B,RASMUSSEN L E,et al.Selective impairment of lymphocyte reactivity to varicellazoster virus antigen among untreated patients with lymphoma[J].J Inf Dis,1978,137(5):531-540.
[15]OXMAN M N,LEVIN M J,JOHNSON G R,et al.A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults[J].Curr Neur Neurosci Rep,2005,5(6):427-428.
[16]YUKIKO T,YOSHIYUKI M,MASAYUKI O,et al.Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a communitybased prospective cohort study:the SHEZ study[J].JEpidem,2015,25(10):617-625.
[17]LARUSSA P,LUNGU O,HARDY I,et al.Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates[J].J Virol,1992,66(2):1016-1020.
[18]LOPAREV V N,GONZALEZ A,DELEONCARNES M,et al.Global identification of three major genotypes of varicella-zoster virus:longitudinal clustering and strategies for genotyping[J].J Virol,2004,78(15):8349-8358.
[2]GERSHON A A,HUTTO C.Varicella-zoster virus[J].Aus Inf Cont,1996,9(3):361.
[3]GERSHON A A,STEINBERG S,BRUNELL P A.Zoster immune globulin,a further assessment[J].New Engl JMed,1974,290(5):243.
[4]INSINGA R P,ITZLER R F,PELLISSIER J M,et al.The incidence of herpes zoster in a United States administrative database[J].J Gene Int Med,2005,20(8):748-753.
[5]张锡宝,曾凡钦.水痘及带状疱疹治疗现状和进展[J].皮肤性病诊疗学杂志,2001,8(1):54-57.
[6]吴根鹏,朱为.水痘-带状疱疹疫苗的使用现状及研究进展[J].中国生物制品学杂志,2016,29(3):323-328.
[7]KATZ S L.Varicella and herpes zoster vaccines:WHOposition paper,June 2014[J].Wkly Epidemiol Rec,2014,89(25):265-287.
[8]SCHMIDT-CHANASIT J,SAUERBREI A.Evolution and world-wide distribution of varicella-zoster virus clades[J].Inf Gene Evol J Mole Epidem Evoly Gene Inf Dis,2011,11(1):1-10.
[9]李杰,陈超美.CiteSpace:科技文本挖掘及可视化[M].北京:首都经济贸易大学出版社,2006:1-244.
[10]SYNNESTVEDT M B,CHEN C,HOLMES J H.Cite Space II:visualization and knowledge discovery in bibliographic databases[J].AMIA Annu Symp Proc,2005:724-728.
[11]CHEN C.CiteSpace II:detecting and visualizing emerging trends and transient patterns in scientific literature[J].JAsso Inf Sci Technol,2009,57(3):359-377.
[12]SANFORD M,KEATING G M.Zoster vaccine(Zostavax):a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults[J].Drugs Aging,2010,27(2):159-176.
[13]MERCK&CO.,INC.Zoster vaccine(Zostavax)[DB/OL].[2009-02-05].http://www.merck.com/product/patent/home.html.
[14]ARVIN A M,POLLARD R B,RASMUSSEN L E,et al.Selective impairment of lymphocyte reactivity to varicellazoster virus antigen among untreated patients with lymphoma[J].J Inf Dis,1978,137(5):531-540.
[15]OXMAN M N,LEVIN M J,JOHNSON G R,et al.A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults[J].Curr Neur Neurosci Rep,2005,5(6):427-428.
[16]YUKIKO T,YOSHIYUKI M,MASAYUKI O,et al.Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a communitybased prospective cohort study:the SHEZ study[J].JEpidem,2015,25(10):617-625.
[17]LARUSSA P,LUNGU O,HARDY I,et al.Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates[J].J Virol,1992,66(2):1016-1020.
[18]LOPAREV V N,GONZALEZ A,DELEONCARNES M,et al.Global identification of three major genotypes of varicella-zoster virus:longitudinal clustering and strategies for genotyping[J].J Virol,2004,78(15):8349-8358.